Fennec Pharmaceuticals (FENC) CSO Christiana Cioffi Receives 156 Shares

What Happened

• Christiana Marie Cioffi, Chief Strategy Officer of Fennec Pharmaceuticals (FENC), received 156 shares on 2026-09-30. The filing reports the acquisition as an award/release (code A) at $0.00 per share (total reported value $0), representing shares that were previously restricted.

Key Details

• Transaction date: 2026-09-30; Filing date (accession): 2026-10-01 — appears timely.
• Price: $0.00 per share; Total reported acquisition value: $0.
• Shares involved: 156 shares released from restriction.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: F1 — these 156 shares were released from restrictions tied to an award granted on 2025-03-28.
• No indication of a sale, 10b5-1 plan, tax withholding, or cashless exercise in this filing.

Context

• This transaction is a release/vesting of previously awarded restricted shares, not an open-market purchase or sale. Such releases are typically part of compensation/vesting schedules and do not by themselves indicate a buying or selling signal from the insider. The small size (156 shares) suggests limited market impact.